Eurotechnology Japan KK

They focus on cross-border M&A, market entry strategy, and business growth acceleration for leading Japanese, European, and US companies—from ventures to multinationals—particularly in pharmaceutical, medical devices, SaaS, semiconductors, and energy sectors.

Check Size

Not specified

Stages

Not specified

Focus Areas

Not specified

Is Eurotechnology Japan KK right for your startup?

Upload your pitch deck and get an AI-powered match score in minutes. See exactly how well you fit their investment criteria.

See If You're a Match

Investment Thesis

Eurotechnology Japan is not a traditional VC firm but rather a boutique M&A advisory and business development firm operating from Tokyo for over 25 years. Their approach is centered on building long-term relationships and trust-based partnerships in Japan, recognizing that ‘business in Japan is much more relationship based, than purely transaction based.’ They emphasize careful, systematic preparation and execution for cross-border transactions, often requiring years of relationship-building before successful deals close.

What Sets Them Apart

Unique scientific and technical foundation: founder Gerhard Fasol holds PhD from Cambridge's Cavendish Laboratory in Physics and brings deep semiconductor research expertise
25+ years of continuous operations from Tokyo base with deep market knowledge and institutional relationships
Board Director-level experience in Japanese corporations (e.g., GMO GlobalSign Holdings KK, Tokyo Stock Exchange code 3788)
Science-based methodology using 'diligent scientific methods and technologies – eg semiconductor physics, data science, statistics, mathematics – where applicable'
Direct relationship-building approach: avoiding third-party introductions to prevent information leakage; typically accessing Japanese C-suite directly within 1-2 months
Community building through Trinity Japan (Cambridge alumni network) and Ludwig Boltzmann Forum connecting Japanese and European/US leadership